
European Lithium (ASX: EUR) hit its target price after a high-volume breakout from consolidation, rallying to A$0.39. A proposed US$835M acquisition by Critical Metals Corp and renewed interest in its lithium and rare earth assets drove the surge.

Encounter Resources (ASX: ENR) is an Australian mineral explorer targeting copper and critical minerals. Backed by solid funding and major partnerships, its share price exhibits bullish reversal signs, though future growth relies heavily on successful high-grade exploration discoveries.

Dimerix shares plunged 35–40% amid heavy selling and uncertainty around clinical updates, worsened by weak biotech sentiment. Further downside depends on results and the funding outlook, though volatility in early-stage biotech stocks suggests a potential for sharp rebounds.

Nuix remains in a weak downtrend despite a bounce toward ~$1.5. The stock is consolidating between ~$1.1–$1.5, showing stabilisation but no confirmed bottom. A breakout above resistance is needed, with risks still skewed to the downside.

Lodestar Minerals has surged ~129% YTD after a breakout to ~$0.028, with potential upside toward $0.03–$0.04 if momentum continues. However, as an early-stage explorer, gains are likely event-driven and volatile, with sustainability dependent on exploration success.

Lynas Rare Earths (ASX: LYC) recently broke its short-term uptrend due to weak Q3 production, facility outages, and expansion costs. Technical analysis indicates strong downside momentum, with the next major support zone sitting lower around the $16.00–$16.23 level.